Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: A multicenter analysis of 772 patients

World Journal of Urology

Volumn 29, Issue 4, 2011, Pages 487-494

  Otto, Wolfgang ^a   Shariat, Shahrokh F ^b   Fritsche, Hans Martin ^a   Gupta, Amit ^b   Matsumoto, Kazumasa ^c   Kassouf, Wassim ^d   Martignoni, Guido ^e   Walton, Thomas J ^f   Tritschler, Stefan ^g   Baba, Shiro ^c   Bastian, Patrick J ^g   Martínez Salamanca, Juan I ^h   Seitz, Christian ⁱ   Pycha, Armin ⁱ   Burger, Maximilian ^a   Karakiewicz, Pierre I ^j   Ficarra, Vincenzo ^k   Novara, Giacomo ^k  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF VERONA   (Italy)

^f ROYAL DERBY HOSPITAL   (United Kingdom)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ CENTRAL HOSPITAL OF BOLZANO   (Italy)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

^k UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

Cancer specific survival; Carcinoma in situ; Transitional cell carcinoma; Upper tract urothelial carcinoma; UTUC collaboration group

Indexed keywords

AGED; ARTICLE; ASIA; CARCINOMA; CARCINOMA IN SITU; CLINICAL TRIAL; COMORBIDITY; EUROPE; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEPHRON; NORTH AMERICA; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; URETER; URINARY TRACT CANCER; UROLOGIC SURGERY; UROTHELIUM;

AGED; ASIA; CARCINOMA; CARCINOMA IN SITU; COMORBIDITY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRONS; NORTH AMERICA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; UROTHELIUM;

EID: 79960698829     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0645-8     Document Type: Article

References (25)

1. Genega EM, Porter CR (2002) Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review. Am J Clin Pathol 117(Suppl): S36.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4): 225-249.
3. Cai G, Liu X, Wu B (2009) Treatment of upper urinary tract urothelial carcinoma. Surg Oncol (Epub ahead of print).
4. Raman JD, Ng CK, Scherr DS et al (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 57(6): 1072-1079.
5. Remzi M, Haitel A, Margulis V et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103(3): 307-311.
6. Isbarn H, Jeldres C, Shariat SF et al (2009) Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 182(5): 2177-2181.
7. Novara G, De Marco V, Gottardo F et al (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110(8): 1715-1722.
8. Bolenz C, Shariat SF, Fernandez MI et al (2009) Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 103(3): 302-306.
9. Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27(4): 612-618.
10. Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6): 1224-1233.
11. Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57(6): 1064-1071.
12. Roscigno M, Shariat SF, Margulis V et al (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181: 2482.
13. Roscigno M, Shariat SF, Margulis V et al (2009) The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur Urol 56(3): 512-518.
14. Zigeuner R, Shariat SF, Margulis V et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57(4): 575-581.
15. Roscigno M, Shariat SF, Freschi M et al (2009) Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology 74(5): 1070-1074.
16. Lughezzani G, Jeldres C, Isbarn H et al (2010) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75(1): 118-124.
17. Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3): 466-475.
18. Shariat SF, Weizer AZ, Green A et al (2000) Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. Urology 56(5): 735-740.
19. Shariat SF, Pahlavan S, Baseman AG et al (2001) E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57(1): 60-65.
20. Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined tcc at radical cystectomy. Eur Urol 51(1): 152-160.
21. Shariat SF, Palapattu GS, Amiel GE et al (2006) Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology 68(3): 538-542.
22. Kojima Y, Tozawa K, Kawai N, Sasaki S, Hayashi Y, Kohri K (2006) Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy. Int J Urol 13(4): 340-344.
23. Wheat JC, Weizer AZ, Stuart Wolf J et al (2010) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol (Epub ahead of print).
24. Greene FL, Page DL, Fleming ID et al (2002) American Joint Committee on Cancer (AJCC) staging manual, 6th edn. Springer, Philadelphia.
25. Mostofi FK, Sobin LH, Torloni H (1973) Histological typing of urinary bladder tumours. World Health Organisation.